3,544
Views
230
CrossRef citations to date
0
Altmetric
Research Article

Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation

, , , &
Pages 228-243 | Received 06 Aug 2009, Accepted 11 Sep 2009, Published online: 09 Nov 2009

References

  • Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252.
  • Bard, D. R., Knight, C. G., Page-Thomas, D. P. (1982). Toxicity of liposomal N–acyl daunorubicins to L929 cells in culture. Br J Cancer 45:783–785.
  • Barenholz, Y. (2003). Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res 13:1–8.
  • Batzri, S., Korn, E. D. (1973). Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 298:1015–1019.
  • Betageri, G. V., Parsons, D. L. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm 81:235–241.
  • Bridges, P. A., Taylor, K. M. (2000). An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharm 204:69–79.
  • Budai, M., Szógyi, M. (2001). Liposomes as drug carrier systems. Preparation, classification, and therapeutic advantages of liposomes. Acta Pharm Hung 71:114–118.
  • Campbell, M. J. (1995). Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques 18:1027–1032.
  • Carneiro, A., Santana, M. (2004). Production of liposomes in a multitubular system useful for scaling up of processes. Progr Coll Polym Sci 128:273–277.
  • Darwis, Y., Kellaway, I. W. (2001). Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int J Pharm 215:113–121.
  • Dass, C. R., Walker, T. L., Burton, M. A. (2002). Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency. Drug Deliv 9:11–18.
  • Desai, T. R., Hancock, R. E. W., Finlay, W. H. (2002). A facile method of delivery of liposomes by nebulization. J Contr Rel 84:69–78.
  • Diab, R., Degobert, G., Hamoudeh, M., Dumontet, C., Fessi, H. (2007). Nucleoside analogue delivery systems in cancer therapy. Exp Opin Drug Deliv 4:513–531.
  • Domazou, A., Luisi, P. (2002). Size distribution of spontaneously formed liposomes by the alcohol injection method. J Liposome Res 12:205–220.
  • Epstein, H., Gutman, D., Cohen-Sela, E., Haber, E., Elmalak, O., Koroukhov, N., et al. (2008). Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization. AAPS J 10:505–515.
  • Fang, J. Y., Hong, C. T., Chiu, W. T., Wang, Y. Y. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72.
  • Fessi, H., Puissieux, F., Devissaguet, J., Thies, C. (1988). Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent no.: 5118528.
  • Gregoriadis, G., Davis, C. (1979). Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Bioph Res Co 89:1287–1293.
  • Gulati, M., Grover, M., Singh, S., Singh, M. (1998). Lipophilic drug derivatives in liposomes. Int J Pharm 165:129–168.
  • Gómez, C., Blanco, M. D., Bernardo, M. V., Olmo, R., Muñiz, E., Teijón, J. M. (2004). Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: in vitro and in vivo studies. Eur J Pharm Biopharm 57:225–233.
  • Güven, A., Ortiz, M., Constanti, M., O’Sullivan, C. K. (2009). Rapid and efficient method for the size separation of homogeneous fluorescein-encapsulating liposomes. J Liposome Res 19:148–154.
  • Hitzman, C. J., Elmquist, W. F., Wattenberg, L. W., Wiedmann, T. S. (2006). Development of a respirable, sustained release microcarrier for 5-fluorouracil I: in vitro assessment of liposomes, microspheres, and lipid coated nanoparticles. J Pharm Sci 95:1114–1126.
  • Hunt, C. A., Rustum, Y. M., Mayhew, E., Papahadjopoulos, D. (1979). Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. Drug Metab Dispos 7:124–128.
  • Isele, U., van Hoogevest, P., Hilfiker, R., Capraro, H. G., Schieweck, K., Leuenberger, H. (1994). Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents. J Pharm Sci 83:1608–1616.
  • Jaafar-Maalej, C., Andrieu, V., Elaissari, A., Fessi, H. (2009). Assessment methods of inhaled aerosols: technical aspects and applications. Exp Opin Drug Deliv [Epub ahead of print].
  • Juliano, R. L., MucCullough, H. N. (1980). Controlled deivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system. J Pharmacol Exp Ther 214:381–387.
  • Juliano, R. L., Stamp, D., McCullogh, N. (1978). Pharmacokinetics of liposomes encapsulated antitumor drugs and implications for therapy. Ann N Y Acad Sci 308:411–423.
  • Justo, O. R., Moraes, A. M. (2005). Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment. J Pharm Pharmacol 57:23–30.
  • Karathanasis, E., Ayyagari, A. L., Bhavane, R., Bellamkonda, R. V., Annapragada, A. V. (2005). Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Contr Rel 103:159–175.
  • Kesisoglou, F., Zhou, S. Y., Niemiec, S., Lee, J. W., Zimmermann, E. M., Fleisher, D. (2005). Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model. Pharm Res 22:1320–1330.
  • Kikuchi, H., Yamauchi, H. (1987). Method for producing liposomes. US Patent no.: 4687661.
  • Kirby, C. J., Gregoriadis, G. (1984). Preparation of liposomes containing factor VIII for oral treatment of haemophilia. J Microencapsul 1:33–45.
  • Knoll, G., Burger, K. N., Bron, R., van Meer, G., Verkleij, A. J. (1988). Fusion of liposomes with the plasma membrane of epithelial cells: fate of incorporated lipids as followed by freeze fracture and autoradiography of plastic sections. J Cell Biol 107:2511–2521.
  • Kremer, J. M., Esker, M. W., Pathmamanoharan, C., Wiersema, P. H. (1977). Vesicles of variable diameter prepared by a modified injection method. Biochemistry 16:3932–3935.
  • Kulkarni, S. B., Betageri, G. V., Singh, M. (1995). Factors affecting microencapsulation of drugs in liposomes. J Microencapsul 12:229–246.
  • Lasic, D. D. (1988). The mechanism of vesicle formation. Biochem J 256:1–11.
  • Liu, D. Z., Chen, W. Y., Tasi, L. M., Yang, S. P. (2000). Micro-calorimetric and shear studies on the effects of cholesterol on the physical stability of lipid vesicles. Coll Surf A 172:57–67.
  • Lopez-Pinto, J. M., Gonzalez-Rodriguez, M. L., Rabasco, A. M. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1–12.
  • Maitani, Y., Soeda, H., Junping, W., Takayama, K. (2001). Modified ethanol injection method for liposomes containing beta-sitosterol beta-d-glucoside. J Liposome Res 11:115–25.
  • Majoral, C., Le Pape A., Diot, P., Vecellio, L. (2006). Comparaison of various methods for processing cascade impactor data. Aerosol Sci Tech 40:672–682.
  • Massing, U., Fuxius, S. (2000). Liposomal formulations of anticancer drugs: selectivity and effectiveness. Drug Res Update 3:171–177.
  • Mayhew, E., Rustum, Y. M., Szoka, F., Papahadjopoulos, D. (1979). Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. Cancer Treat Rep 63:1923–1928.
  • McCullough, H. N., Juliano, R. L. (1979). Organ-selective action of an antitumor drug: pharmacologic studies of liposomes-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat. J Natl Cancer Inst 63:727–731.
  • Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., Perrie, Y. (2004). Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 285:23–34.
  • Naeff, R. (1996). Feasibility of topical liposome drugs produced on an industrial scale. Adv Drug Deliv Rev 18:343–347.
  • Patel, K. R., Baldeschwieler, J. D. (1984). Treatment of intravenously implanted Lewis lung carcinoma with liposome-encapsulated cytosine arabinoside and nonspecific immunotherapy. J Int Cancer 34:415–420.
  • Pons, M., Foradada, M., Estelrich, J. (1993). Liposomes obtained by the ethanol injection method. Int J Pharm 95:51–56.
  • Rustum, Y. M., Dave, C., Mayhew, E., Papahadjopoulos, D. (1979). Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia. Cancer Res 39:1390–1395.
  • Saari, S. M., Vidgren, M. T., Koskinen, M. O., Turjanmaa, V. M., Waldrep, J. C., Nieminen, M. M. (1998). Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. Chest 113:1573–1579.
  • Schipper, N. G., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Vårum, K. M., Artursson, P. (1997). Chitosans as absorption enhancers for poorly absorbable drugs. 2: mechanism of absorption enhancement. Pharm Res 14:923–929.
  • Schubert, M. A., Müller-Goymann, C. C. (2003). Solvent injection as a new approach for manufacturing lipid nanoparticles—evaluation of the method and process parameters. Eur J Pharm Biopharm 55:125–131.
  • Sebti, T., Amighi, K. (2006). Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm 63:51–58.
  • Sezer, A. D., Akbuğa, J., Baş, A. L. (2007). In vitro evaluation of enrofloxacin-loaded MLV liposomes. Drug Deliv 14:47–53.
  • Sonar, S., D’Souza, S. E., Mishra, K. P. (2008). A simple one-step protocol for preparing small-sized doxorubicin-loaded liposomes. J Environ Pathol Tox 27:181–189.
  • Stano, P., Bufali, S., Pisano, C., Bucci, F., Barbarino, M., Santaniello, M., et al. (2004). Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J Liposome Res 14:87–109.
  • Suarez, S., Hickey, A. J. (2000). Drug properties affecting aerosol behavior. Respir Care 45:652–666.
  • Sze, A., Erickson, D., Ren, L., Li, D. (2003). Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow. J Coll Interf Sci 261:402–410.
  • Szoka, F. J., Papahadjopoulos, D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S Am 75:4194–4198.
  • Tomoko, N., Fumiyoshi, I. (2005). Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198–205.
  • Vemuri, S., Yu, C. D., Wangsatorntanakun, V., Roosdorp, N. (1990). Large-scale production of liposomes by a microfluidizer. Drug Dev Ind Pharm 16:2243–2256.
  • Vidgren, M., Silvasti, M., Korhonen, P., Kinkelin, A., Frischer, B., Stern, K. (1995). Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol. Arzneimittel-Forschung 45:44–47.
  • Wagner, A., Vorauer-Uhl, K., Katinger, H. (2002). Liposomes produced in a pilot scale: production, purification, and efficiency aspects. Eur J Pharm Biopharm 54:213–219.
  • Waldrep, J. C., Gilbert, B. E., Knight, C. M., Black, M. B., Scherer, P. W., Knight, V., et al. (1997). Pulmonary delivery of beclomethasone liposome aerosol in volunteers: tolerance and safety. Chest 111:316–323.
  • Waldrep, J. C., Keyhani, K., Black, M., Knight, V. (1994). Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 105:106–110.
  • Xu, P., Gullotti, E., Tong, L., Highley, C. B., Errabelli, D. R., Hasan, T., et al. (2009). Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharmaceut 6:190–201.
  • Yan, E. C., Eisenthal, K. B. (2000). Effect of cholesterol on molecular transport of organic cations across liposome bilayers probed by second harmonic generation. Biophys J 79:898–903.
  • Yang, X., Zhao, X., Phelps, M. A., Piao, L., Rozewski, D. M., Liu, Q., et al. (2009). A novel liposomal formulation of flavopiridol. Int J Pharm 365:170–174.
  • Zaru, M., Mourtas, S., Klepetsanis, P., Fadda, A. M., Antimisiaris, S. G. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 67:655–666.
  • Zhang, Y. L., Frangos, J. A., Chachisvilis, M. (2006).. Laurdan fluorescence senses mechanical strain in the lipid bilayer membrane. Biochem Biophys Res Commun 347:838–841.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.